Our top pick for
Building a portfolio
Varian Medical Systems, Inc is a medical instruments & supplies business based in the US. Varian Medical Systems shares (VAR) are listed on the NYSE and all prices are listed in US Dollars. Varian Medical Systems employs 10,000 staff and has a trailing 12-month revenue of around USD$3.1 billion.
|52-week range||USD$103.67 - USD$177.38|
|50-day moving average||USD$176.28|
|200-day moving average||USD$174.5792|
|Wall St. target price||USD$177.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$3.032|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Varian Medical Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Varian Medical Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Varian Medical Systems's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 58x. In other words, Varian Medical Systems shares trade at around 58x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Varian Medical Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.8331. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Varian Medical Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Varian Medical Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$524.5 million.
The EBITDA is a measure of a Varian Medical Systems's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$3.1 billion|
|Operating margin TTM||13.63%|
|Gross profit TTM||USD$1.4 billion|
|Return on assets TTM||5.92%|
|Return on equity TTM||13.51%|
|Market capitalisation||USD$16.3 billion|
TTM: trailing 12 months
There are currently 2.9 million Varian Medical Systems shares held short by investors – that's known as Varian Medical Systems's "short interest". This figure is 12.2% down from 3.4 million last month.
There are a few different ways that this level of interest in shorting Varian Medical Systems shares can be evaluated.
Varian Medical Systems's "short interest ratio" (SIR) is the quantity of Varian Medical Systems shares currently shorted divided by the average quantity of Varian Medical Systems shares traded daily (recently around 782103.97877984). Varian Medical Systems's SIR currently stands at 3.77. In other words for every 100,000 Varian Medical Systems shares traded daily on the market, roughly 3770 shares are currently held short.
However Varian Medical Systems's short interest can also be evaluated against the total number of Varian Medical Systems shares, or, against the total number of tradable Varian Medical Systems shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Varian Medical Systems's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Varian Medical Systems shares in existence, roughly 30 shares are currently held short) or 0.0411% of the tradable shares (for every 100,000 tradable Varian Medical Systems shares, roughly 41 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Varian Medical Systems.
Find out more about how you can short Varian Medical Systems stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Varian Medical Systems.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 26.98
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Varian Medical Systems's overall score of 26.98 (as at 12/31/2018) is nothing to write home about – landing it in it in the 49th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Varian Medical Systems is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 6.23/100
Varian Medical Systems's environmental score of 6.23 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Varian Medical Systems is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 15.82/100
Varian Medical Systems's social score of 15.82 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Varian Medical Systems is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 12.93/100
Varian Medical Systems's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that Varian Medical Systems is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Varian Medical Systems scored a 1 out of 5 for controversy – the highest score possible, reflecting that Varian Medical Systems has managed to keep its nose clean.
|Total ESG score||26.98|
|Total ESG percentile||48.96|
|Environmental score percentile||4|
|Social score percentile||4|
|Governance score percentile||4|
|Level of controversy||1|
We're not expecting Varian Medical Systems to pay a dividend over the next 12 months.
Varian Medical Systems's shares were split on a 10000:8769 basis on 29 January 2017. So if you had owned 8769 shares the day before before the split, the next day you'd have owned 10000 shares. This wouldn't directly have changed the overall worth of your Varian Medical Systems shares – just the quantity. However, indirectly, the new 12.3% lower share price could have impacted the market appetite for Varian Medical Systems shares which in turn could have impacted Varian Medical Systems's share price.
Over the last 12 months, Varian Medical Systems's shares have ranged in value from as little as $103.67 up to $177.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Varian Medical Systems's is 1.0695. This would suggest that Varian Medical Systems's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.
Steps to owning and managing NSE, with 24-hour and historical pricing before you buy.
Steps to owning and managing NPA, with 24-hour and historical pricing before you buy.
Steps to owning and managing NFH, with 24-hour and historical pricing before you buy.
Steps to owning and managing NEP, with 24-hour and historical pricing before you buy.
Steps to owning and managing NEN, with 24-hour and historical pricing before you buy.
Steps to owning and managing NTST, with 24-hour and historical pricing before you buy.
Steps to owning and managing NSYS, with 24-hour and historical pricing before you buy.
Steps to owning and managing NOA, with 24-hour and historical pricing before you buy.
Steps to owning and managing NMM, with 24-hour and historical pricing before you buy.
Steps to owning and managing NMCI, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.